Skip to main content

Table 2 Basic information of HCV patients in different hypoxia-based clusters

From: Exploration of a hypoxia-immune-related microenvironment gene signature and prediction model for hepatitis C-induced early-stage fibrosis

Characteristics

Whole cohort (216)

Hypoxia low (82)

Hypoxia high (134)

Survival

150 (69.44%)

64 (78.05%)

86 (64.18%)

Survival time (days)

3373.13 ± 1525.10

3514.67 ± 1531.66

3286.52 ± 1520.29

Bilirubin ≥ 1.0 mg/dl

108 (50.00%)

38 (46.34%)

70 (52.24%)

HCC

65 (30.09%)

21 (25.61%)

44 (32.84%)

  1. HCC Hepatic carcinoma, HCV hepatitis C virus